These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6211612)

  • 1. [Dosage of Cefoperazone in Normal and Restricted Renal Function (author's transl].
    Piper C; Koeppe P; Höffler D
    MMW Munch Med Wochenschr; 1982 Mar; 124(10):244-8. PubMed ID: 6211612
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats.
    Balant L; Dayer P; Rudhardt M; Allaz AF; Fabre J
    Clin Ther; 1980; 3(Spec Issue):50-9. PubMed ID: 6446399
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of ceftazidime in normal and impaired renal function.
    Höffler D; Koeppe P; Williams KJ
    Arzneimittelforschung; 1984; 34(1):72-6. PubMed ID: 6367755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalexin in patients with renal disease.
    Linquist JA; Siddiqui JY; Smith IM
    N Engl J Med; 1970 Oct; 283(14):720-3. PubMed ID: 5454765
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
    Höffler D; Koeppe P
    Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney transport of cefapirin in normal and impaired renal function.
    Brodwall EK; Orjavik O; Bergan T
    Arzneimittelforschung; 1981; 31(12):2157-9. PubMed ID: 7199318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro studies on dosing interval of cefoperazone (author's transl)].
    Shah PM; Racky K; Stille W
    Arzneimittelforschung; 1981; 31(3):482-5. PubMed ID: 6452882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities of glomerular filtration value estimation from endogenous creatinine plasma concentration (author's transl)].
    Nádvorníková H; Schück O; Prát V
    Cas Lek Cesk; 1976 Aug; 115(33-34):1011-5. PubMed ID: 975171
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.
    Greenfield RA; Gerber AU; Craig WA
    Rev Infect Dis; 1983; 5 Suppl 1():S127-36. PubMed ID: 6221382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefapirin in patients with normal and impaired renal functions.
    Bergan T; Orjavik O; Brodwall EK
    Arzneimittelforschung; 1981; 31(10):1773-6. PubMed ID: 7198453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Choice of amoxycilin dosage in impaired renal function (author's transl)].
    Dzúriková V; Simkovicová M; Fedelesová V; Dzúrik R
    Bratisl Lek Listy; 1978 Apr; 69(4):468-73. PubMed ID: 638809
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function.
    Spruill WJ; Wade WE; Cobb HH
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):153-60. PubMed ID: 18775390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentration of cefoperazone in various tissues of the urogenital system (author's transl)].
    Schalkhäuser K; Adam D
    Arzneimittelforschung; 1981; 31(10):1770-2. PubMed ID: 6459099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the pharmacokinetics of latamoxef in normal and impaired renal function.
    Höffler D; Koeppe P; Moecke D
    Arzneimittelforschung; 1984; 34(3):317-20. PubMed ID: 6539614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of intravenous Cefradin in normal and restricted renal function (author's transl)].
    Höffler D; Koeppe P
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1169-74. PubMed ID: 808712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum levels of a new cephalosporin, cephacetrile, as a function of renal excretion capacity].
    Brogard JM; Ruscher H; Frankhauser J; Kuntzmann F; Lavillaureix J
    Pathol Biol (Paris); 1973 Jun; 21(6):671-9. PubMed ID: 4581199
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobials in renal impairment.
    Lefrock JL; Smith BR
    Am Fam Physician; 1982 Jun; 25(6):201-5. PubMed ID: 7081009
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of renal excretion of ceftizoxime in rabbits and dogs (author's transl)].
    Murakawa T; Nakamoto S; Nishida M
    Jpn J Antibiot; 1980 Jun; 33(6):679-84. PubMed ID: 6935443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of ceftazidime in normal and impaired renal function.
    Höffler D; Koeppe P; Williams KJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():241-5. PubMed ID: 6352626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The correlation between radiographic appearance and contrast excretion during infusion urography with dissimilar renal function (author's transl)].
    Bahlmann J; Holsten D
    Fortschr Geb Rontgenstr Nuklearmed; 1974 Jun; 120(6):686-91. PubMed ID: 4368279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.